Efficacy and Safety of Fruquintinib Plus PD-1 Inhibitors Versus Regorafenib Plus PD-1 Inhibitors in Refractory Microsatellite Stable Metastatic Colorectal Cancer

Li‐Ying Sun(Nanchang University), Jianbing Wu(Nanchang University)

Frontiers in Oncology

October 6, 2021

10.3389/fonc.2021.754881

Cited by 39

Related Papers

No related papers found

Powered by citation graph analysis